Rituximab and lenalidomide combination treatment for rheumatoid arthritis complicated with myelodysplastic syndrome:
Gerasimos Evangelatos1, Ioanna Vlachadami2, Maria Kechagia1
1Rheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece.
Abstract:
Rheumatoid arthritis patients might experience several hematologic complications. The development of myelodysplastic syndrome is not clearly associated with RA, even though it has been described in some patients with pre-existing disease. There are only few data available in the literature concerning the therapeutic approach of such patients. Herein, we report a case of RA complicated with progressive MDS, successfully treated with rituximab and lenalidomide combination therapy.
More Related Videos
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
